ACP-5862 is a major active and pyrrolidine ring-opened metabolite of Acalabrutinib (IC50: 5.0 nM for BTK). Acalabrutinib is an irreversible and highly selective BTK inhibitor (IC50: 3 nM; EC50: 8 nM).
Fmoc-ε-Acp-OH can be used as a PROTAC linker in the synthesis of PROTACs and other conjugation applications. Fmoc-ε-Acp-OH is an alkane chian with terminal Fmoc-protected amine and carboxylic acid groups. The Fmoc group can be deprotected under basic condition to obtain the free amine which can be used for further conjugations. The terminal carboxylic acid can react with primary amine groups in the presence of activators (e.g. EDC, or HATU) to form a stable amide bond.
Acyl Carrier Protein (ACP) (65-74) is an active fragment of ACP, a component of plastid-located plant fatty acid synthetase. It covalently binds acyl groups via the prosthetic group, 4-phosphopantetheine.
SL-017 (ACP-SL-017, ACPSL-017, ACP-SL-017) is a Hypocrellin-B (Hb) derivative and photosensitization agent that may be used to treat abnormal hair growth. SL017 targets the mitochondria and causes the mitochondrial membrane potential to collapse, producin